INTRODUCTION
I n A r g e n t i n a , a s p a r t o f a comprehensive strategy to prevent cervical cancer, in 2011 the National Ministry of Health introduced the human papillomavirus (HPV) vaccine in the national immunization schedule (NIS). 1 However, immunization success will depend on achieving a high level of coverage, which is strongly subjected to users' and health care providers' acceptance. 2 In Argentina, the burden of this disease is not homogeneous and varies depending on the geographic location. It is very high among populations with a lower level of socioeconomic development. Additionally, regional mortality rates reflect such variability; in increasing order, as follows: South, Center, Cuyo, Northwest, and Northeast. 3 The impact of this disease may be partly avoided by prophylactic HPV vaccination. It has been demonstrated that this intervention prevents 77% of cervical neoplasms associated with HPV serotypes 16 and 18, prevalent in cervical cancer (CC). 4 Currently available vaccines in Argentina have proven effective and safe to prevent HPV serotypes 16 and 18 related lesions and to provide cross-protection against serotypes 31, 33, 45, 52 and 58, not included in the vaccine. However, its long-term effectiveness to prevent cervical cancer has not been fully demonstrated. [5] [6] [7] Common adverse effects are mild and include pain, swelling or redness at the injection site. Fever and nausea are also common, but these were not more frequent among girls who received the HPV vaccine than in other girls who received a placebo injection. These adverse effects usually resolve spontaneously in one or two days. 8 A c c o r d i n g t o t h e E x t e n d e d Immunization Program established by the province of Chaco, the second dose of the HPV vaccine reached a c o v e r a g e a m o n g t h e s t u d i e d population of 24.55% in the first semester of 2012, a much lower percentage than what had been expected. Our hypothesis was that guardians' acceptance may be one of the factors associated to a low level of immunization coverage, explained by certain sociodemographic and psychosocial factors.
The general objective of this study was to establish the level of acceptance of the HPV vaccine by guardians of candidate girls in an area of Resistencia, Chaco, in Northeast Argentina.
Specific objectives were as follows: a) to establish the coverage of HPV vaccination in girls who are in the appropriate age group; and b) to explore the association between guardians' intention to have girls vaccinated and sociodemographic and psychosocial factors.
METHODOLOGY

Type of study
A descriptive, qualitative and quantitative study was conducted between April and October 2012.
Population: guardians who reported making decisions regarding girls' health (mother, father, legal tutor and/or representative), living in the sphere of influence of a primary care service in the city of Resistencia, Chaco, in 2012.
Sampling
A single randomized sampling was done based on school enrollment lists of 11 yearold female students. If girls had more than one guardian, the person responsible for making decisions about the girl's health was selected.
Guardians were invited to participate in school meetings based on a schedule established for each school. If a guardian did not attend, they were visited at home.
Analysis unit: guardians were randomly selected based on lists of 11 year-old girls included in the class lists of public primary education schools located in the sphere of influence of the city's referral health care center.
Exclusion criteria: guardians who were unable to speak or complete the questionnaire or who refused to participate in the study.
Sample size: from a total of 560 schoolgirls with a 60% prevalence of acceptability among guardians and an alpha error of 0.02 (according to scientific publications from Canada and the United States of America), 9 the final sample was estimated to be 300 guardians.
Method
Source of information. Measuring instrument
A specially designed structured questionnaire made up of four constructs was used; it assessed overall acceptability by means of guardians' intention to have girls vaccinated. Each construct included three items measured using a Likerttype scale (1 to 5). 1: strongly disagree; 2: disagree; 3: neither agree nor disagree; 4: agree; 5: strongly agree. A pilot study was conducted to test the questionnaire. The measuring instrument showed an acceptable internal consistency of 70% (Cronbach's alpha: 0.701). (Annex).
Dependent outcome measure
Overall acceptability. Overall acceptability was assessed using constructs based on the theory of planned behavior. The total score was obtained and a score of 50 points or more was used as a cut-off point; any score above 50 was deemed as accepting vaccination.
Definition of constructs that make up vaccine acceptability
• Intention: behavioral intention is the most direct factor, and closest to behavior. perceived ease or difficulty of performing a particular behavior; it is assumed that it reflects both past experience and anticipation of hurdles and obstacles.
INDEpENDENT OUTCOME MEASURES Sociodemographic factors of the guardian:
• Sex: female-male.
• Age: in years.
• • Income level: family household monthly income in Argentine pesos, categorized into less than $1000, from $1000 to $2500, from $2600 to $4000, from $4100 to $6000, and over $6000.
• Presence of a family member with cancer: yes/no.
Factors related to knowledge
• Knowledge about HPV: yes/no.
• HPV vaccination coverage for the first dose:
yes/no.
Statistical analysis
A univariate analysis was performed. Mean and standard deviation were estimated for quantitative outcome measures, while the ratio and 95% confidence interval (CI) were calculated for qualitative outcome measures. A bivariate analysis was then developed to assess the relationship between qualitative outcome measures (overall acceptability) and sociodemographic outcome measures. The χ² test was used to determine independence among groups. A p value <0.05 was considered statistically significant. An unconditional logistic regression was done for the multivariate analysis.
The Epi Info™ and IBM SPSS Statistics version 21.0.0 (SPSS, Inc, Chicago, Illinois) software programs were used.
Ethical aspects
The study was not subjected to an assessment by a Research Ethics Committee because it was part of a pilot project for the implementation of HPV immunization managed by the Provincial I m m u n i z a t i o n P r o g r a m c a l l e d N a t i o n a l Program for the Control of Vaccine-Preventable Diseases (Programa Nacional de Control de EnfermedadesInmunoprevenibles, ProNaCEI) as routine monitoring of vaccination coverage levels. Study participants were not exposed to any risk; notwithstanding, informed consent was obtained from those who voluntarily agreed to participate in the study. For data confidentiality purposes, the survey was completed anonymously, and anonymization mechanisms were established for outcome measures that could have identified participants. In addition, formal agreements were made between the Ministry of Education and the Ministry of Health regarding access to lists of schoolgirls.
RESULTS
Out of 12 selected schools (300 guardians), two refused to participate (80 guardians). The survey was completed by 100 guardians (75 women) from the remaining 10 schools (220 guardians). Twenty-three surveys were excluded from the analysis due to missing data. Surveys completed by 77 guardians were included for analysis; 84.2% of guardians were women with an average age of 38.3 years old. The expected sample size was not attained due to budgetary and logistic issues and, also, because of guardians' low response rate. In the end, the power of the study for this sample size was 64%. Although lower than what has been usually reported, we believe that this is an acceptable power for an exploratory study.
As per the information provided by guardians, 46.1% (95% CI: 34.5-57.9) of candidate girls had received the first vaccine dose ( Table 1) .
In relation to the guardians' level of education, 21% had completed tertiary or university education, 51.3% had completed secondary education, and 25%, primary education.
The rate of overall acceptance was observed to be 46.6% (95% CI: 34.8-58.6).
Knowledge about the vaccine introduced in the national immunization schedule was associated with its acceptance, although such association was not statistically significant (OR: 2.21, 95% CI: 0.87-5.62, p = 0.09). HPV vaccination coverage for the first dose as reported by guardians was associated with acceptance; its OR was 4.08 (95% CI: 1.56-10.68, p = 0.003) ( Table 2) .
Following a multivariate analysis, for the best selected model, only the coverage for the first dose (adjusted OR: 8.02, 95% CI: 2.29-28.01, p = 0.0011) was associated with overall acceptance, adjusted by knowledge about the HPV vaccine, knowledge about HPV, socioeconomic level, age, sex, family member with cervical cancer, candidate girls for the vaccine, and religion (Table 3) .
DISCUSSION
Our findings show that overall acceptability of the vaccine was lower than what has been published by other authors, who observed a 60-70% acceptance rate in other countries, including Canada and the United States of America. Such difference in estimations may be partly explained by the low power of our study to detect differences. [10] [11] [12] Based on survey respondents' sex and age, it was possible to observe that most guardians were middle-aged women, similarly to what has been described in other studies. This is because women are usually the ones responsible for making decision regarding girls' health. [10] [11] [12] Other studies that analyzed the set of outcome measures, including age, education level, socioeconomic level, number of candidate girls and religion, found no statistically significant differences in terms of vaccine acceptance. [12] [13] [14] However, some authors have stated that the level of education is associated with a higher adherence to immunization schedules. 10, 15 In a study conducted by Ogilvie et al. in 2010, parents with a higher level of education were less prone to give their consent to have their daughters receive the HPV vaccine (63.3% versus 72.9%, p < 0.01). 10 In addition, a qualitative study done in Colombia observed that families with a higher education and socioeconomic level, represented by parents of boys and girls attending private schools, showed a greater critical capacity towards scientific information received, which translated into a clearly hesitant attitude towards information about the vaccine. 16 It is worth noting that our study found no association between education level and acceptability, probably because the socioeconomic and education level of survey respondents were rather homogeneous considering that respondents belonged to a confined area of the city.
Having a family history of cancer was not associated with a greater vaccine acceptance. However, this finding is contrary to what was reported by Ogilvie et al. in 2010, who described that parents who had a family member with cervical cancer were more likely to accept HPV vaccination (OR: 1.5, 95% CI: 1.1-2.1). 10 In general, the proportion of immunized girls varies between and within countries, as well as in relation to continuity of immunization with the second dose. For example, a survey administered among parents of almost 3000 girls aged between 12 and 13 years old in Manchester (United Kingdom) showed a vaccination coverage of 70.6% for the first dose, 17 while Fang et al. reported, based on a national American survey (HINTS), a 37% coverage in that population. 12 As per the ProNaCEI data, average coverage for the complete immunization schedule in Argentina was estimated to be 50.2% for the cohort of girls born in 2000-2001, and it was lower in the province of Chaco. 18 This finding is consistent with our results, which reflect the need to implement strategies aimed at improving the level of coverage.
In terms of finding an explanation for causative factors of vaccine acceptability, guardians' prior knowledge about the vaccine may be a determining factor for acceptability; however, our study found no statistically significant association. [10] [11] [12] [13] It might be interesting to look into the reasons for which guardians refuse vaccination and explore other outcome measures, such as confidence in physicians or the health care system and communication between guardians and girls regarding sexuality from a qualitative perspective. 16 Another factor to be studied might be the criterion of pediatricians who provide care to this population and who may be influenced at the time of advising girls' guardians.
It is very important to improve immunization coverage levels in Argentina. In this regard, some international experiences to improve immunization adherence may be of help. In Canada, specifically in British Columbia, a school-based immunization program was implemented. Trained nurses administered the vaccine to girls during school days. This strategy was accompanied by online parental education campaigns, brochures and community discussions to identify and address myths around HPV vaccination. 10 A potential limitation to our study might be that it only considered guardians of girls attending public schools, leaving out private sector facilities.
However, beyond its limitations, we expect that this pilot study serves as the basis for future, larger scale and in-depth applications of studied outcome measures. At the same time, it is a reliable instrument to measure the rate of acceptance of a new vaccine introduced in the national immunization schedule in settings where there is a high prevalence of cervical cancer.
CONCLUSIONS
Data herein analyzed reveal a low rate of acceptance, consistent with the level of coverage for the first dose as reported by guardians. However, no demographic or psychosocial characteristic was associated with the guardians' decision to have their girls receive the HPV vaccine. n
